Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Classement en actions #33690
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Prix de l'action
$4.70
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.09M
Changement (1 jour)
-0.21%
Changement (1 an)
-70.63%
Pays
US
Échange Apimeds Pharmaceuticals US, Inc (APUS)

Catégorie

Historique du prix de l'action pour Apimeds Pharmaceuticals US, Inc (APUS)
Prix de clôture le plus élevé : $4.53 le 2026-08-01

Prix de clôture le plus bas : $18.03 le 2025-05-01
Historique du prix de l'action de Apimeds Pharmaceuticals US, Inc de 2025 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -15.19%
2025 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$505.24 28.63%
US
$846.09 29.41%
NL
$731.95 6.51%
CH
$1.07K -6.40%
KR
$254.79 13.07%
BE